Clincosm LogoSign in Get a demo

Non Small Cell Lung Cancer

Showing NaN - NaN of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer Trial in Worldwide (Telisotuzumab Vedotin, Docetaxel)

Recruiting
  • Non Small Cell Lung Cancer
  • Los Angeles, California
  • +212 more
Jan 26, 2023

Solid Tumor, Non Small Cell Lung Cancer, Pancreatic Cancer Trial in Israel, United States (CM-24 and Nivolumab - Dose

Recruiting
  • Solid Tumor
  • +6 more
  • CM-24 and Nivolumab - Dose Escalation
  • +4 more
  • Scottsdale, Arizona
  • +10 more
Jan 17, 2023

Gastric Cancer, Renal Cell Carcinoma, Melanoma Trial in United States (HFB200301)

Recruiting
  • Gastric Cancer
  • +8 more
  • Scottsdale, Arizona
  • +9 more
Dec 22, 2022

Non Small Cell Lung Cancer, KRAS Activating Mutation Trial in Worldwide (VS-6766, VS-6766 and Defactinib)

Recruiting
  • Non Small Cell Lung Cancer
  • KRAS Activating Mutation
  • avutometinib (VS-6766)
  • avutometinib (VS-6766) and Defactinib
  • Duarte, California
  • +44 more
Dec 22, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Taletrectinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Beverly Hills, California
  • +58 more
Dec 13, 2022

Non Small Cell Lung Cancer Trial in Worldwide (AZD9291)

Active, not recruiting
Has Results
  • Non Small Cell Lung Cancer
  • La Jolla, California
  • +43 more
Nov 25, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Amivantamab, Lazertinib, Zirabev)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Angers, France
  • +30 more
Oct 31, 2022

Advanced Solid Tumors, Colorectal Cancer, Non Small Cell Lung Cancer Trial in France, Spain (CAN04 (nadunolimab), mFOLFOX, DTX)

Active, not recruiting
  • Advanced Solid Tumors
  • +3 more
  • CAN04 (nadunolimab)
  • +3 more
  • Saint-Herblain, Boulevard Jacques Monod, France
  • +5 more
Oct 20, 2022

Non Small Cell Lung Cancer Trial in Spain (Tipifarnib)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Santiago De Compostela, A Coruña, Spain
  • +29 more
Sep 21, 2022

I3LUNG: Integrative Science, Intelligent Data Platform for

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
    • Chicago, Illinois
    • +3 more
    Sep 13, 2022

    Non Small Cell Lung Cancer Trial in Worldwide (Telisotuzumab Vedotin)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Telisotuzumab Vedotin
    • Clayton, Victoria, Australia
    • +54 more
    Aug 23, 2022

    Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

    Available
    • Non Small Cell Lung Cancer
    • +6 more
    • Goodyear, Arizona
    • +67 more
    Aug 17, 2022

    Non Small Cell Lung Cancer Trial in Spain (Paclitaxel, Carboplatin, Nivolumab)

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • Badalona, Barcelona, Spain
    • +24 more
    Aug 5, 2022

    Solid Tumor, Adult, Head Neck Cancer, Non Small Cell Lung Cancer Trial in Worldwide (CX-2029)

    Active, not recruiting
    • Solid Tumor, Adult
    • +4 more
    • Birmingham, Alabama
    • +24 more
    Aug 5, 2022

    Non Small Cell Lung Cancer Trial in Worldwide (Capmatinib, Nazartinib)

    Terminated
    • Non Small Cell Lung Cancer
    • Boston, Massachusetts
    • +18 more
    Jul 20, 2022

    Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

    Recruiting
    • Ovarian Cancer
    • +10 more
    • West Hollywood, California
    • +27 more
    Jun 27, 2022

    Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

    Completed
    • Melanoma
    • +6 more
    • Combination of NKTR-214 + nivolumab
    • La Jolla, California
    • +57 more
    Jun 22, 2022

    Non Small Cell Lung Cancer Trial in Spain (Atezolizumab-Bevacizumab)

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • Santiago De Compostela, A Coruña, Spain
    • +24 more
    Jun 1, 2022

    Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer Trial in Spain (Ipilimumab, Nivolumab, Carboplatin)

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • Badalona, Barcelona, Spain
    • +17 more
    Jun 1, 2022

    Osimertinib in Advanced Non-Small Cell Lung Cancer EGFR-T790M

    Completed
    • Non Small Cell Lung Cancer
    • Oviedo, Asturias, Spain
    • +30 more
    Jun 1, 2022

    Non Small Cell Lung Cancer Trial in Spain (Pembrolizumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • L'Hospitalet de Llobregat, Barcelona, Spain
    • +11 more
    May 4, 2022

    Thyroid, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (SO-C101, pembrolizumab)

    Recruiting
    • Thyroid
    • +18 more
    • New Haven, Connecticut
    • +6 more
    Apr 8, 2022

    Non Small Cell Lung Cancer Trial in Worldwide (Nivolumab, Cisplatin, Vinorelbine)

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • Nivolumab
    • +8 more
    • Glendale, Arizona
    • +135 more
    Feb 28, 2022

    Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Cancer, Melanoma Trial in Worldwide (MGC018, retifanlimab)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +5 more
    • MGC018
    • retifanlimab
    • Santa Monica, California
    • +19 more
    Feb 14, 2022

    Non Small Cell Lung Cancer Trial in Worldwide (EGF816, INC280, Nivolumab)

    Terminated
    Has Results
    • Non Small Cell Lung Cancer
    • Houston, Texas
    • +12 more
    Jan 31, 2022